Boundless Bio, Inc.

NASDAQ: BOLD · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001782303Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 44DQ —GM —SS 54

v0.1 · 35/100 weight · pillars only

↑ filing timeliness, balance-sheet leverage · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$58.2M

Employees

Market cap

$56.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$58.2M-$58.2M2025

Operating income-$63.6M-$63.6M2025

Total assets$157.1M$157.1M2025

Liabilities$58.4M$58.4M2025

Equity$98.7M$98.7M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Boundless Bio, Inc. earned -$58.2M in FY2025 net income.

Peers · Healthcare

Spectral AI, Inc.39D BioStem Technologies, Inc.——Fractyl Health, Inc.28D DocGo Inc.44D

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Sempra$12.4B64C Realty Income Corporation$5.7B59C ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+DexCom, Inc.$4.7B87A

Key facts

CEOZachary Hornby

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: BOLD

Employees64

IPO date2016-07-20

Latest filings

8-K2026-06-23 8-K2026-06-17 10-Q2026-05-08 8-K2026-05-08 DEF 14A2026-04-28 8-K2026-04-13 8-K2026-03-09 10-K2026-03-09

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.